Advanced BioMedical Technologies, Inc.

OTCPK:ABMT Stock Report

Market Cap: US$28.4k

Advanced BioMedical Technologies Management

Management criteria checks 1/4

We currently do not have sufficient information about the CEO.

Key information

Hui Wang

Chief executive officer

n/a

Total compensation

CEO salary percentagen/a
CEO tenureno data
CEO ownershipn/a
Management average tenureno data
Board average tenure14yrs

Recent management updates

No updates

Recent updates

CEO Compensation Analysis

How has Hui Wang's remuneration changed compared to Advanced BioMedical Technologies's earnings?
DateTotal CompensationSalaryCompany Earnings
Jul 31 2021n/an/a

-US$753k

Apr 30 2021n/an/a

-US$760k

Jan 31 2021n/an/a

-US$780k

Oct 31 2020US$35kUS$35k

-US$672k

Jul 31 2020n/an/a

-US$726k

Apr 30 2020n/an/a

-US$734k

Jan 31 2020n/an/a

-US$760k

Oct 31 2019US$35kUS$35k

-US$949k

Jul 31 2019n/an/a

-US$1m

Apr 30 2019n/an/a

-US$1m

Jan 31 2019n/an/a

-US$983k

Oct 31 2018US$37kUS$37k

-US$953k

Compensation vs Market: Insufficient data to establish whether Hui's total compensation is reasonable compared to companies of similar size in the US market.

Compensation vs Earnings: Insufficient data to compare Hui's compensation with company performance.

CEO

Hui Wang (54 yo)

no data

Tenure

US$34,602

Compensation

Ms. Hui Wang serves as the Chief Executive Officer and Controller of Advanced BioMedical Technologies, Inc. Ms. Wang serves as General Manager of Shenzhen Changhua. She started her career at Hainan Xinte P...

Board Members

NamePositionTenureCompensationOwnership
Hui Wang
CEO, Controller & Directorno dataUS$34.60kno data
Chi Ming Yu
Presidentno dataUS$15.30kno data
Kai Gui
Secretaryno dataUS$22.95kno data
Shangli Liu
Chairman of Scientific Board & Chief Medical Advisor of Greater China13.5yrsno datano data
John Harrington
Chairman of Advisory Board14yrsno datano data
Donald Varshine
Member of Advisory Board14yrsno datano data
Lamont Woody
Member of Advisory Board14yrsno datano data
Frank Pelaia
Member of Advisory Board14yrsno datano data
Thomas Deberardino
Member of Scientific Board13.5yrsno datano data
Hani Awad
Member of Scientific Board13.5yrsno datano data

14.0yrs

Average Tenure

54yo

Average Age

Experienced Board: ABMT's board of directors are seasoned and experienced ( 14 years average tenure).

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/05/01 15:54
End of Day Share Price 2025/04/08 00:00
Earnings2021/07/31
Annual Earnings2020/10/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Advanced BioMedical Technologies, Inc. is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.